{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:31:55Z","timestamp":1761532315531,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.brachy.2023.08.009","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:14:14Z","timestamp":1696864454000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Redefining bladder neck dose in low-dose-rate prostate brachytherapy\u2013Can we improve urinary toxicity without impacting disease control?"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2034-2393","authenticated-orcid":false,"given":"Sean A.","family":"Koerner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald M.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3063-8991","authenticated-orcid":false,"given":"Ryan P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.08.009_bib0001","unstructured":"American Cancer Society Key statistics for prostate cancer. Website, Available at: https:\/\/www.cancer.org\/cancer\/prostate-cancer\/about\/key-statistics.html. Accessed November 13, 2021."},{"key":"10.1016\/j.brachy.2023.08.009_bib0002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.6004\/jnccn.2021.0008","article-title":"NCCN Guidelines Insights: Prostate Cancer, Version 1.2021","volume":"19","author":"Schaeffer","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.brachy.2023.08.009_bib0003","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.eururo.2019.10.030","article-title":"Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received","volume":"77","author":"Neal","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0004","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","article-title":"Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review","volume":"72","author":"Lardas","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0005","doi-asserted-by":"crossref","first-page":"430.e1","DOI":"10.1016\/j.urolonc.2016.04.015","article-title":"Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: a secondary analysis of RTOG 94-08 and 96-01","volume":"34","author":"Mak","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0006","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.brachy.2015.12.011","article-title":"Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapy","volume":"15","author":"Eriguchi","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.009_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.radonc.2007.05.020","article-title":"A prospective analysis of long-term quality of life after permanent I-125 brachytherapy for localised prostate cancer","volume":"84","author":"Ash","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0008","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ijrobp.2005.03.046","article-title":"Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry","volume":"63","author":"Van Gellekom","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0009","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ijrobp.2004.12.061","article-title":"Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05","volume":"62","author":"Feigenberg","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(99)00355-7","article-title":"A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer","volume":"46","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0011","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.urology.2009.12.084","article-title":"Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131","volume":"76","author":"Jacobs","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2023.08.009_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1118\/1.597458","article-title":"Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43","volume":"22","author":"Nath","year":"1995","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0013","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.brachy.2008.05.004","article-title":"Recommendations for permanent prostate brachytherapy with 131Cs: a consensus report from the Cesium Advisory Group","volume":"7","author":"Bice","year":"2008","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.009_bib0014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0094-0143(05)70304-9","article-title":"Functional anatomy of the organs of micturition","volume":"23","author":"Elbadawi","year":"1996","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.brachy.2023.08.009_bib0016","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.radonc.2020.10.003","article-title":"Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: an EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.08.009_bib0017","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2023.08.009_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.urology.2014.08.044","article-title":"Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form","volume":"85","author":"Skolarus","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.brachy.2023.08.009_bib0019","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.ijrobp.2011.02.037","article-title":"Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis","volume":"81","author":"Zilli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijrobp.2007.12.052","article-title":"Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapy","volume":"72","author":"Thomas","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.08.009_bib0021","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.brachy.2019.02.003","article-title":"Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: impact on acute urinary toxicity and health-related quality of life","volume":"18","author":"Sanmamed","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.08.009_bib0022","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brachy.2020.06.011","article-title":"Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy","volume":"19","author":"Boyce-Fappiano","year":"2020","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212301632X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212301632X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:19:15Z","timestamp":1761531555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847212301632X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S153847212301632X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.009","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining bladder neck dose in low-dose-rate prostate brachytherapy\u2013Can we improve urinary toxicity without impacting disease control?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}